Latest Strategy News

Otto Energy Limited has clarified that part of its recent capital return will be treated as a dividend according to a draft ATO ruling, prompting shareholders to consider tax implications carefully.

Credit Intelligence Ltd has announced a conditional agreement to sell its loss-making subsidiary Credit Intelligence Holding Limited for AUD 1.5 million, pending shareholder approval and regulatory clearances.

Nanoveu Limited has successfully completed the second tranche of its upsized capital raise, securing $720,000 through share issuance and listed options, with a final $400,000 tranche pending shareholder approval.

Toys"R"Us ANZ Limited reported a significant increase in product margins and sales revenue despite inventory challenges, while advancing a recapitalisation plan to secure its financial future.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Galileo Mining has agreed to extend key terms of its lithium joint venture with Mineral Resources at the Norseman project, adjusting payment timelines and earn-in periods to support ongoing exploration.

Tamboran Resources has successfully closed the first tranche of its PIPE, raising US$38.7 million to advance its Beetaloo Basin projects, with a second tranche pending shareholder approval.

Austco Healthcare has completed its strategic acquisition of New Zealand’s G&S Technologies, enhancing its healthcare communication offerings and direct sales reach in the region.

Arcadia Minerals' recent stream sediment sampling across Namibia's Tantalite Valley Complex reveals promising new areas rich in nickel, copper, lithium, and precious metals, expanding the project's exploration potential.

Emmerson Resources’ joint venture partner Tennant Mining has begun commercial gold production at the Nobles Project near Tennant Creek, setting the stage for potential royalty payments and future development opportunities.

Askari Metals has reported partial uptake in its recent entitlement offer for new options, raising about half of the targeted funds, with plans underway to complete the shortfall. The move supports ongoing exploration projects in lithium and uranium.

Cardiex Digital Vascular Biomarkers announces a A$6.5 million equity raise to fund inventory, marketing, product development, and debt repayment, aiming to solidify its position in the expanding cardiovascular health market.